DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer, currently the Company’s President, has been appointed as Chief Operating Officer (“COO”). As President, Mr. Sayer is responsible for the Company’s research and development, manufacturing, clinical, regulatory and finance functions. Mr. Sayer will continue to lead those groups, and with the additional responsibility as COO, Mr. Sayer will also lead DexCom’s sales, marketing, and other core commercial functions. Mr. Sayer will continue to report to Terry Gregg, DexCom's Chief Executive Officer.
"Kevin and I have worked closely together now for nearing twenty years, and we share the same vision for the Company. I am very confident that his proven track record of successfully building and operating medical device businesses, his keen knowledge of our business and industry, and his leadership skill will help us achieve our goals and fulfill our potential,” said Terry Gregg.
“Kevin's appointment will also help me continue to direct more of my energies on developing and refining our corporate strategy, and to enhancing DexCom's external relationships with customers, shareholders, and key constituents, both domestically and internationally," continued Mr. Gregg.
Mr. Sayer has served as DexCom's President since June 2011, and as a board member since November 2007. From April 2007 to December 2010, Mr. Sayer served as Chief Financial Officer of Biosensors International Group, Ltd. (“Biosensors”), a medical technology company developing, manufacturing and commercializing medical devices used in interventional cardiology and critical care procedures. Previously, Mr. Sayer served as Chief Financial Officer of MiniMed, Inc. from 1994 until its acquisition by Medtronic, Inc. in 2001. He also has served as Executive Vice President and Chief Financial Officer of Specialty Laboratories, Inc., and as an independent healthcare and medical technology industry consultant. Mr. Sayer received his Master’s Degree in Accounting and Information Systems concurrently with a B.A., both from Brigham Young University.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV